Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Stem Cell Transplant Group:
- People who are willing to give their informed consent to take part in the study
- People who are willing to follow all study procedures and stay involved for the full duration of the study
- People who have a confirmed diagnosis of multiple myeloma, certain types of Non-Hodgkin lymphoma (including DLBCL, mantle cell lymphoma, follicular lymphoma, or peripheral T-cell lymphoma), or Hodgkin lymphoma, as confirmed through medical records
- People for whom a first autologous stem cell transplant (a transplant using the patient's own stem cells) has been recommended by their doctor as a standard treatment
- People aged 19 years or older
CAR T-Cell Therapy Group:
- People who are willing to give their informed consent to take part in the study
- People who are willing to follow all study procedures and stay involved for the full duration of the study
- People who have a confirmed diagnosis of lymphoma or multiple myeloma, and whose condition meets the standard criteria for CAR T-cell therapy as recommended by their doctor
- People aged 19 years or older
Who may not be able to join:
Stem Cell Transplant Group:
- People who have had weight-loss surgery in the past, such as gastric banding, sleeve gastrectomy, or gastric bypass, or who have a long-term bowel or gut condition such as ongoing diarrhoea or inflammatory bowel disease
- People who have previously had a bad reaction to fibre supplements
- People who are allergic or intolerant to potato starch or maltodextrin (a type of food additive)
- People who are not willing to provide stool (bowel movement) samples as part of the study
- People the study doctors consider unsuitable for other reasons (confirm with trial site)
CAR T-Cell Therapy Group:
- People who have had weight-loss surgery in the past, such as gastric banding, sleeve gastrectomy, or gastric bypass, or who have a long-term bowel or gut condition, or other gut surgery that the study doctor believes could reduce the safety or effectiveness of the treatment
- People who have previously had a bad reaction to fibre supplements
- People who are allergic or intolerant to resistant starch or maltodextrin (a type of food additive)
- People who are not willing to provide stool (bowel movement) samples as part of the study
- People the study doctors consider unsuitable for other reasons (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Christopher R D'Angelo, MD, University of Nebraska
Phone: 402-559-3810
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of subjects who adhere to >70% of scheduled doses of the intervention
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.